Diabetes mellitus medication assistance program: Relationship of effectiveness to adherence

Journal of Health Care for the Poor and Underserved

Volumn 19, Issue 3, 2008, Pages 677-686

  Horswell, Ronald L ^a,e   Wascom, Charles K ^b   Cerise, Frederick P ^c   Besse, Jay A ^a   Johnson, Jolene K ^d  

^a Louisiana State University Health Care Services Division

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c Louisiana State University System   (United States)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NONE   (United States)

Author keywords

Adherence; Diabetes mellitus; Glycosylated hemoglobin; Hemoglobin A1c; Indigent; Medication assistance program; Public hospital

Indexed keywords

EID: 49849102061     PISSN: 10492089     EISSN: None     Source Type: Journal    
DOI: 10.1353/hpu.0.0062     Document Type: Article

References (27)

1. Geyman JP. Disease management: panacea, another false hope, or something in between? Ann Fam Med. 2007 May-Jun;5(3):257-60.
2. Druss BG, Marcus SC, Olfson M, et al. Comparing the national economic burden of five chronic conditions. Health Aff (Millwood). 2001 Nov-Dec;20(6):233-41.
3. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Public Health. 2004 Oct;94(10):1782-7.
4. Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: how well are states closing the gap? Health Aff (Millwood). 2002 Jul-Dec;Suppl Web Exclusives:W253-68.
5. Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med. 2001 Dec;16(12):793-9.
6. Kennedy J, Erb C. Prescription noncompliance due to cost among adults with disabilities in the United States. Am J Public Health. 2002 Jul;92(7):1120-4.
7. Taylor H, Leitman R. Out-of pocket cost are a substantial barrier to prescription drug compliance. Health Care News. 2001 Nov;1(32):1-2 Available at http://www. harrisinteractive.com/news/newsletters/healthnews/ HI_HealthCareNews2001Vol1_ iss32.pdf.
8. Centers of Medicare and Medicaid Services. National Health Expenditure Projections 2006-2016. Available at http://www.cms.hhs.gov/ NationalHealthExpendData/downloads/proj2006.pdf.
9. Poisal J, Truffer C, Smith S, et al. Health spending projections through 2016: modest changes obscure part D's impact. Health Aff (Millwood). 2007 Mar-Apr;26(2): W242-53. Epub 2007 Feb 21.
10. National Institute for Health Care Management. Prescription drug expenditures in 2001: another year of escalating costs Available at http://www.nihcm.org/∼nihcmor/pdf/spending2001.pdf.
11. Dubois RW, Chawla AJ, Neslusan CA, et al. Explaining drug spending trends: does perception match reality? Health Aff (Millwood). 2000 Mar-Apr;19(2):231-9.
12. Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004 Feb;27(2):384-91.
13. Piette JD, Wagner TH, Potter MB, et al. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care. 2004 Feb;42(2):102-9.
14. Klein R, Klein BEK, Moss SE, et al. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med. 1994 Oct 10; 154(19):2169-78.
15. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998 Sep 12;352(9131):837-53. Erratum in: Lancet. 1999 Aug 14;354(9178):602.
16. Schectman JL, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002 Jun; 25(6):1015-21.
17. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986 April;73:13-22.
18. McCullagh P, Neider JA. Generalized linear models. 2nd Edition. London: Chapman and Hall, 1989.
19. Hardin JW, Hilbe JM. Generalized estimating equations. Boca Raton, FL: Chapman and Hall/CRC, 2003.
20. Sidak Z. Rectangular confidence regions for the means of multivariate normal distributions. J Am Stat Assoc. 1967;62:626-33.
21. Shih WJ. On informative and random dropouts in longitudinal studies. Biometrics. 1992 Sep;48(3):970-2.
22. Global Medical Instrumentation, Inc. Beckman Coulter Synchron CX3, CX5, CX7 Delta, CX9 Chemistry Analyzer. Ramsey, MN: Global Medical Instrumentation, Inc., 2007. Available at http://www.gmiinc.com/Products/ Beckman%20CX5%20chemistry. htm.
23. StataCorp. Stata Statistical Software: Release 9. College Station, TX: StataCorp LP, 2005.
24. Charlson ME, Pompei P, Alex KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83.
25. Wiener K, Roberts NB. Age does not influence levels of HbA1c in normal subject. Q J Med. 1999;92:169-73.
26. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). 1998 Sep 12;352(9131):837.
27. Strum MW, Hopkins R, West DS, et al. Effects of a medication assistance program on health outcomes in patients with type 2 diabetes mellitus. Am J Health Syst Pharm. 2005 May 15;62(10):1048-52.